EXPEDITED REVIEW
Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla
Edward T. Martin, MS, MD, FACC* ,*,
James A. Coman, MD, FACC*,
Frank G. Shellock, PhD ,
Christopher C. Pulling, MS ,
Robert Fair, ARRT(R) (MR)* and
Kim Jenkins, ARRT(R) (MR)*
* Oklahoma Heart Institute, Tulsa, Oklahoma, USA
University of Oklahoma, Tulsa, Oklahoma, USA
University of Southern California, Keck School of Medicine and Institute of Magnetic Resonance Safety, Education, and Research, Los Angeles, California, USA
Integra CTS, Minneapolis, Minnesota, USA
* Reprint requests and correspondence: Dr. Edward T. Martin, Oklahoma Heart Institute, 9228 South Mingo Road, Tulsa, Oklahoma 74133, USA.
martin{at}oklahomaheart.com
OBJECTIVES: The study was done to determine whether patients with pacemakers could safely undergo magnetic resonance imaging (MRI) at 1.5-Tesla (T).
BACKGROUND: Because of theoretical risks, it is an absolute contraindication for a patient with a pacemaker to undergo MRI. However, there are times when an MRI is needed to provide valuable clinical information.
METHODS: Fifty-four patients underwent a total of 62 MRI examinations at 1.5-T. The type of MRI examination was not limited and included cardiac, vascular, and general MRI studies using various whole-body averaged specific absorption rate (SAR) of radiofrequency power. Restrictions were not placed on the type of pacemaker present in the patient. All pacemakers were interrogated immediately before and after MRI scanning, and patients were continuously monitored. Before and after MRI, interrogation was done, and pacing and sensing thresholds, as well as lead impedances, were all measured.
RESULTS: A total of 107 leads and 61 pulse generators were evaluated. No adverse events occurred. Forty (37%) of the leads underwent changes, whereas 10 (9.4%) leads underwent a significant change. Only 2 of the 107 (1.9%) leads required a change in programmed output. Threshold changes were unrelated to cardiac chamber, anatomical location, peak SAR, and time from lead implant to the MRI examination. Electrocardiographic changes and patient symptoms were minor and did not require cessation of MRI.
CONCLUSIONS: Safety was demonstrated in this series of patients with pacemakers at 1.5-T.
|
Abbreviations and Acronyms
| | ACLS | = advanced cardiac life support | | ECG | = electrocardiographic/electrocardiography | | MR | = magnetic resonance | | MRA | = magnetic resonance angiography | | MRI | = magnetic resonance imaging | | RF | = radiofrequency | | SAR | = specific absorption rate |
|
This article has been cited by other articles:
|
|
|
|
 
A. Roguin
Magnetic resonance imaging in patients with implantable cardioverter-defibrillators and pacemakers.
J. Am. Coll. Cardiol.,
August 4, 2009;
54(6):
556 - 557.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. P. Naehle, C. Meyer, D. Thomas, S. Remerie, C. Krautmacher, H. Litt, R. Luechinger, R. Fimmers, H. Schild, and T. Sommer
Safety of Brain 3-T MR Imaging with Transmit-Receive Head Coil in Patients with Cardiac Pacemakers: Pilot Prospective Study with 51 Examinations
Radiology,
December 1, 2008;
249(3):
991 - 1001.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Benza, R. Biederman, S. Murali, and H. Gupta
Role of Cardiac Magnetic Resonance Imaging in the Management of Patients With Pulmonary Arterial Hypertension
J. Am. Coll. Cardiol.,
November 18, 2008;
52(21):
1683 - 1692.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Roguin, J. Schwitter, C. Vahlhaus, M. Lombardi, J. Brugada, P. Vardas, A. Auricchio, S. Priori, and T. Sommer
Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices
Europace,
March 1, 2008;
10(3):
336 - 346.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. N. Levine, A. S. Gomes, A. E. Arai, D. A. Bluemke, S. D. Flamm, E. Kanal, W. J. Manning, E. T. Martin, J. M. Smith, N. Wilke, et al.
Safety of Magnetic Resonance Imaging in Patients With Cardiovascular Devices: An American Heart Association Scientific Statement From the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: Endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance
Circulation,
December 11, 2007;
116(24):
2878 - 2891.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Kramer, M. J. Budoff, Z. A. Fayad, V. A. Ferrari, C. Goldman, J. R. Lesser, E. T. Martin, S. Rajagopalan, J. P. Reilly, G. P. Rodgers, et al.
ACCF/AHA 2007 Clinical Competence Statement on vascular imaging with computed tomography and magnetic resonance
Vascular Medicine,
November 1, 2007;
12(4):
359 - 378.
[PDF]
|
|
|
|
|
|
|
C. M. Kramer, M. J. Budoff, Z. A. Fayad, V. A. Ferrari, C. Goldman, J. R. Lesser, E. T. Martin, S. Rajagopalan, J. P. Reilly, G. P. Rodgers, et al.
ACCF/AHA 2007 Clinical Competence Statement on Vascular Imaging With Computed Tomography and Magnetic Resonance: A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training Developed in Collaboration With the Society of Atherosclerosis Imaging and Prevention, the Society for Cardiovascular Angiography and Interventions, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society for Vascular Medicine and Biology
J. Am. Coll. Cardiol.,
September 11, 2007;
50(11):
1097 - 1114.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. H. McCollough, J. Zhang, A. N. Primak, W. J. Clement, and J. R. Buysman
Effects of CT Irradiation on Implantable Cardiac Rhythm Management Devices
Radiology,
June 1, 2007;
243(3):
766 - 774.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. J. Ferris, H. Kavnoudias, C. Thiel, and S. Stuckey
The 2005 Australian MRI Safety Survey
Am. J. Roentgenol.,
May 1, 2007;
188(5):
1388 - 1394.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Mikolich and E. T. Martin
Constrictive Pericarditis Diagnosed by Cardiac Magnetic Resonance Imaging in a Pacemaker Patient
Circulation,
February 20, 2007;
115(7):
e191 - e193.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J.W. Gotte, T. Germans, I. K. Russel, J. J.M. Zwanenburg, J. T. Marcus, A. C. van Rossum, and D. J. van Veldhuisen
Myocardial Strain and Torsion Quantified by Cardiovascular Magnetic Resonance Tissue Tagging: Studies in Normal and Impaired Left Ventricular Function
J. Am. Coll. Cardiol.,
November 21, 2006;
48(10):
2002 - 2011.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Kramer
The Expanding Prognostic Role of Late Gadolinium Enhanced Cardiac Magnetic Resonance
J. Am. Coll. Cardiol.,
November 21, 2006;
48(10):
1986 - 1987.
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. P. Faris and M. Shein
Food and Drug Administration Perspective: Magnetic Resonance Imaging of Pacemaker and Implantable Cardioverter-Defibrillator Patients
Circulation,
September 19, 2006;
114(12):
1232 - 1233.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Sommer, C. P. Naehle, A. Yang, V. Zeijlemaker, M. Hackenbroch, A. Schmiedel, C. Meyer, K. Strach, D. Skowasch, C. Vahlhaus, et al.
Strategy for Safe Performance of Extrathoracic Magnetic Resonance Imaging at 1.5 Tesla in the Presence of Cardiac Pacemakers in Non-Pacemaker-Dependent Patients: A Prospective Study With 115 Examinations
Circulation,
September 19, 2006;
114(12):
1285 - 1292.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Nazarian, A. Roguin, M. M. Zviman, A. C. Lardo, T. L. Dickfeld, H. Calkins, R. G. Weiss, R. D. Berger, D. A. Bluemke, and H. R. Halperin
Clinical Utility and Safety of a Protocol for Noncardiac and Cardiac Magnetic Resonance Imaging of Patients With Permanent Pacemakers and Implantable-Cardioverter Defibrillators at 1.5 Tesla
Circulation,
September 19, 2006;
114(12):
1277 - 1284.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. P. Naehle, H. Litt, T. Lewalter, and T. Sommer
Do we need pacemakers resistant to magnetic resonance imaging?
Europace,
January 1, 2006;
8(5):
388 - 388.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. E. Irnich
Reply to the letter of Naehle et al.
Europace,
January 1, 2006;
8(5):
389 - 389.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. E. Irnich
Reply to the letter of Luechinger et al.
Europace,
January 1, 2006;
8(5):
390 - 391.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Luechinger, V. A. Zeijlemaker, P. Boesiger, and F. Duru
Potential harmful effects of magnetic resonance imaging in pacemaker patients should not be underestimated.
Europace,
January 1, 2006;
8(5):
389 - 390.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. I. Norton, C. Tong, R. B. J. Glass, and J. C. Nielsen
Cardiac MR Imaging Assessment Following Tetralogy of Fallot Repair
RadioGraphics,
January 1, 2006;
26(1):
197 - 211.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Sommer, C. P. Naehle, and H. Schild
Magnetic Resonance Imaging in Patients With Cardiac Pacemakers
J. Am. Coll. Cardiol.,
August 2, 2005;
46(3):
561 - 562.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. T. Martin and J. A. Coman
Reply
J. Am. Coll. Cardiol.,
August 2, 2005;
46(3):
562 - 562.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Gimbel, B. L. Wilkoff, E. Kanal, and M. A. Rozner
Safe, sensible, sagacious: responsible scanning of pacemaker patients
Eur. Heart J.,
August 2, 2005;
26(16):
1683 - 1684.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Budoff, M. C. Cohen, M. J. Garcia, J. McB. Hodgson, W. G. Hundley, J. A.C. Lima, W. J. Manning, G. M. Pohost, P. M. Raggi, G. P. Rodgers, et al.
ACCF/AHA Clinical Competence Statement on Cardiac Imaging With Computed Tomography and Magnetic Resonance: A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training
J. Am. Coll. Cardiol.,
July 19, 2005;
46(2):
383 - 402.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Chen-Scarabelli, T. M. Scarabelli, C. Vahlhaus, T. Sommer, C. P. Naehle, A. Roguin, M. M. Zviman, G. R. Meininger, T. M. Dickfeld, A. Lardo, et al.
Letters Regarding Article by Roguin et al, "Modern Pacemaker and Implantable Cardioverter/Defibrillator Systems Can Be Magnetic Resonance Imaging Safe: In Vitro and In Vivo Assessment of Safety and Function at 1.5 T" * Letters Regarding Article by Roguin et al, "Modern Pacemaker and Implantable Cardioverter/Defibrillator Systems Can Be Magnetic Resonance Imaging Safe: In Vitro and In Vivo Assessment of Safety and Function at 1.5 T" * Letters Regarding Article by Roguin et al, "Modern Pacemaker and Implantable Cardioverter/Defibrillator Systems Can Be Magnetic Resonance Imaging Safe: In Vitro and In Vivo Assessment of Safety and Function at 1.5 T"
Circulation,
June 14, 2005;
111(23):
e390 - e392.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H. Helm, C. Leclercq, O. P. Faris, C. Ozturk, E. McVeigh, A. C. Lardo, and D. A. Kass
Cardiac Dyssynchrony Analysis Using Circumferential Versus Longitudinal Strain: Implications for Assessing Cardiac Resynchronization
Circulation,
May 31, 2005;
111(21):
2760 - 2767.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Luechinger, V. A. Zeijlemaker, E. M. Pedersen, P. Mortensen, E. Falk, F. Duru, R. Candinas, and P. Boesiger
In vivo heating of pacemaker leads during magnetic resonance imaging
Eur. Heart J.,
February 2, 2005;
26(4):
376 - 383.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. T. Martin
Can cardiac pacemakers and magnetic resonance imaging systems co-exist?
Eur. Heart J.,
February 2, 2005;
26(4):
325 - 327.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Rozner, A. W. Burton, and A. Kumar
Pacemaker complication during magnetic resonance imaging
J. Am. Coll. Cardiol.,
January 4, 2005;
45(1):
161 - 162.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Coman and E. T. Martin
Reply
J. Am. Coll. Cardiol.,
January 4, 2005;
45(1):
162 - 162.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. V. Frangioni and R. J. Hajjar
In Vivo Tracking of Stem Cells for Clinical Trials in Cardiovascular Disease
Circulation,
November 23, 2004;
110(21):
3378 - 3383.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Gibbons and P. A. Araoz
The year in cardiac imaging
J. Am. Coll. Cardiol.,
November 16, 2004;
44(10):
1937 - 1944.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Pennell, U. P. Sechtem, C. B. Higgins, W. J. Manning, G. M. Pohost, F. E. Rademakers, A. C. van Rossum, L. J. Shaw, and E. K. Yucel
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report
Eur. Heart J.,
November 1, 2004;
25(21):
1940 - 1965.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S K Prasad and D J Pennell
Safety of cardiovascular magnetic resonance in patients with cardiovascular implants and devices
Heart,
November 1, 2004;
90(11):
1241 - 1244.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. G. Shellock and J. V. Crues
MR Procedures: Biologic Effects, Safety, and Patient Care
Radiology,
September 1, 2004;
232(3):
635 - 652.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Loewy, A. Loewy, and E. J. Kendall
Reconsideration of Pacemakers and MR Imaging
RadioGraphics,
September 1, 2004;
24(5):
1257 - 1267.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Steiner and J. Loewy
Invited Commentary * Author's Response
RadioGraphics,
September 1, 2004;
24(5):
1267 - 1268.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Roguin, M. M. Zviman, G. R. Meininger, E. R. Rodrigues, T. M. Dickfeld, D. A. Bluemke, A. Lardo, R. D. Berger, H. Calkins, and H. R. Halperin
Modern Pacemaker and Implantable Cardioverter/Defibrillator Systems Can Be Magnetic Resonance Imaging Safe: In Vitro and In Vivo Assessment of Safety and Function at 1.5 T
Circulation,
August 3, 2004;
110(5):
475 - 482.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Prince, P. O. Alderson, and H. D. Sostman
Chronic Pulmonary Embolism: Combining MR Angiography with Functional Assessment
Radiology,
August 1, 2004;
232(2):
325 - 326.
[Full Text]
[PDF]
|
|
|
|
